nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.122	0.215	CbGbCtD
Pioglitazone—PTGS1—Etoposide—peripheral nervous system neoplasm	0.089	0.157	CbGbCtD
Pioglitazone—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0852	0.15	CbGbCtD
Pioglitazone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0533	0.0939	CbGbCtD
Pioglitazone—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0514	0.0906	CbGbCtD
Pioglitazone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0495	0.0873	CbGbCtD
Pioglitazone—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0365	0.0643	CbGbCtD
Pioglitazone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0227	0.0401	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0223	0.0394	CbGbCtD
Pioglitazone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0208	0.0367	CbGbCtD
Pioglitazone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0142	0.0251	CbGbCtD
Pioglitazone—PPARG—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.0077	0.728	CbGdCrCtD
Pioglitazone—PPARG—Teniposide—Etoposide—peripheral nervous system neoplasm	0.00288	0.272	CbGdCrCtD
Pioglitazone—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000591	0.0014	CcSEcCtD
Pioglitazone—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000589	0.00139	CcSEcCtD
Pioglitazone—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000588	0.00139	CcSEcCtD
Pioglitazone—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000587	0.00139	CcSEcCtD
Pioglitazone—Neoplasm—Doxorubicin—peripheral nervous system neoplasm	0.000586	0.00139	CcSEcCtD
Pioglitazone—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.000585	0.00138	CcSEcCtD
Pioglitazone—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000583	0.00138	CcSEcCtD
Pioglitazone—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000583	0.00138	CcSEcCtD
Pioglitazone—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.000577	0.00137	CcSEcCtD
Pioglitazone—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000574	0.00136	CcSEcCtD
Pioglitazone—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000574	0.00136	CcSEcCtD
Pioglitazone—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000571	0.00135	CcSEcCtD
Pioglitazone—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000571	0.00135	CcSEcCtD
Pioglitazone—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000568	0.00134	CcSEcCtD
Pioglitazone—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000567	0.00134	CcSEcCtD
Pioglitazone—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.000566	0.00134	CcSEcCtD
Pioglitazone—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000566	0.00134	CcSEcCtD
Pioglitazone—Abnormal vision—Doxorubicin—peripheral nervous system neoplasm	0.000566	0.00134	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000562	0.00133	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.000561	0.00133	CcSEcCtD
Pioglitazone—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00056	0.00133	CcSEcCtD
Pioglitazone—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00056	0.00133	CcSEcCtD
Pioglitazone—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000556	0.00131	CcSEcCtD
Pioglitazone—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000556	0.00131	CcSEcCtD
Pioglitazone—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000555	0.00131	CcSEcCtD
Pioglitazone—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000554	0.00131	CcSEcCtD
Pioglitazone—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000552	0.00131	CcSEcCtD
Pioglitazone—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000551	0.00131	CcSEcCtD
Pioglitazone—Oedema—Vincristine—peripheral nervous system neoplasm	0.000551	0.0013	CcSEcCtD
Pioglitazone—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000551	0.0013	CcSEcCtD
Pioglitazone—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000548	0.0013	CcSEcCtD
Pioglitazone—Infection—Vincristine—peripheral nervous system neoplasm	0.000547	0.00129	CcSEcCtD
Pioglitazone—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000545	0.00129	CcSEcCtD
Pioglitazone—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000541	0.00128	CcSEcCtD
Pioglitazone—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.00128	CcSEcCtD
Pioglitazone—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000541	0.00128	CcSEcCtD
Pioglitazone—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000541	0.00128	CcSEcCtD
Pioglitazone—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00054	0.00128	CcSEcCtD
Pioglitazone—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000538	0.00127	CcSEcCtD
Pioglitazone—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000534	0.00126	CcSEcCtD
Pioglitazone—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000532	0.00126	CcSEcCtD
Pioglitazone—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000531	0.00126	CcSEcCtD
Pioglitazone—Back pain—Etoposide—peripheral nervous system neoplasm	0.000529	0.00125	CcSEcCtD
Pioglitazone—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000525	0.00124	CcSEcCtD
Pioglitazone—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.00124	CcSEcCtD
Pioglitazone—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000521	0.00123	CcSEcCtD
Pioglitazone—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000521	0.00123	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000521	0.00123	CcSEcCtD
Pioglitazone—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00052	0.00123	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000519	0.00123	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000519	0.00123	CcSEcCtD
Pioglitazone—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000517	0.00122	CcSEcCtD
Pioglitazone—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000516	0.00122	CcSEcCtD
Pioglitazone—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000516	0.00122	CcSEcCtD
Pioglitazone—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000509	0.00121	CcSEcCtD
Pioglitazone—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000509	0.00121	CcSEcCtD
Pioglitazone—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.000509	0.0012	CcSEcCtD
Pioglitazone—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000508	0.0012	CcSEcCtD
Pioglitazone—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000508	0.0012	CcSEcCtD
Pioglitazone—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000507	0.0012	CcSEcCtD
Pioglitazone—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000505	0.0012	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000504	0.00119	CcSEcCtD
Pioglitazone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000503	0.00119	CcSEcCtD
Pioglitazone—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000502	0.00119	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000502	0.00119	CcSEcCtD
Pioglitazone—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.00119	CcSEcCtD
Pioglitazone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000499	0.00118	CcSEcCtD
Pioglitazone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000499	0.00118	CcSEcCtD
Pioglitazone—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000498	0.00118	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000493	0.00117	CcSEcCtD
Pioglitazone—Malaise—Etoposide—peripheral nervous system neoplasm	0.000493	0.00117	CcSEcCtD
Pioglitazone—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000493	0.00117	CcSEcCtD
Pioglitazone—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000491	0.00116	CcSEcCtD
Pioglitazone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000487	0.00115	CcSEcCtD
Pioglitazone—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000487	0.00115	CcSEcCtD
Pioglitazone—Infection—Cisplatin—peripheral nervous system neoplasm	0.000484	0.00114	CcSEcCtD
Pioglitazone—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.00114	CcSEcCtD
Pioglitazone—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.00114	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.00114	CcSEcCtD
Pioglitazone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000477	0.00113	CcSEcCtD
Pioglitazone—Headache—Topotecan—peripheral nervous system neoplasm	0.000476	0.00113	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000475	0.00113	CcSEcCtD
Pioglitazone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000475	0.00112	CcSEcCtD
Pioglitazone—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000473	0.00112	CcSEcCtD
Pioglitazone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000472	0.00112	CcSEcCtD
Pioglitazone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000472	0.00112	CcSEcCtD
Pioglitazone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000472	0.00112	CcSEcCtD
Pioglitazone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000471	0.00111	CcSEcCtD
Pioglitazone—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.00111	CcSEcCtD
Pioglitazone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000471	0.00111	CcSEcCtD
Pioglitazone—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00047	0.00111	CcSEcCtD
Pioglitazone—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000465	0.0011	CcSEcCtD
Pioglitazone—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000465	0.0011	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000462	0.00109	CcSEcCtD
Pioglitazone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00046	0.00109	CcSEcCtD
Pioglitazone—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.00046	0.00109	CcSEcCtD
Pioglitazone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000454	0.00107	CcSEcCtD
Pioglitazone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.00107	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000449	0.00106	CcSEcCtD
Pioglitazone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000446	0.00106	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000444	0.00105	CcSEcCtD
Pioglitazone—Infection—Etoposide—peripheral nervous system neoplasm	0.000443	0.00105	CcSEcCtD
Pioglitazone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000442	0.00105	CcSEcCtD
Pioglitazone—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00104	CcSEcCtD
Pioglitazone—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.00103	CcSEcCtD
Pioglitazone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000434	0.00103	CcSEcCtD
Pioglitazone—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000433	0.00103	CcSEcCtD
Pioglitazone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000431	0.00102	CcSEcCtD
Pioglitazone—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.00102	CcSEcCtD
Pioglitazone—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000428	0.00101	CcSEcCtD
Pioglitazone—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000425	0.00101	CcSEcCtD
Pioglitazone—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000423	0.001	CcSEcCtD
Pioglitazone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000422	0.000998	CcSEcCtD
Pioglitazone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000421	0.000997	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00042	0.000995	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000983	CcSEcCtD
Pioglitazone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00041	0.00097	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000409	0.000967	CcSEcCtD
Pioglitazone—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000963	CcSEcCtD
Pioglitazone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000406	0.00096	CcSEcCtD
Pioglitazone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000401	0.00095	CcSEcCtD
Pioglitazone—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.0004	0.000947	CcSEcCtD
Pioglitazone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000398	0.000942	CcSEcCtD
Pioglitazone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000398	0.000941	CcSEcCtD
Pioglitazone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000939	CcSEcCtD
Pioglitazone—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.000938	CcSEcCtD
Pioglitazone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000395	0.000935	CcSEcCtD
Pioglitazone—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000928	CcSEcCtD
Pioglitazone—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000928	CcSEcCtD
Pioglitazone—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000926	CcSEcCtD
Pioglitazone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000391	0.000925	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000385	0.000912	CcSEcCtD
Pioglitazone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000385	0.00091	CcSEcCtD
Pioglitazone—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000902	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000895	CcSEcCtD
Pioglitazone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000378	0.000894	CcSEcCtD
Pioglitazone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000377	0.000892	CcSEcCtD
Pioglitazone—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000376	0.00089	CcSEcCtD
Pioglitazone—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000885	CcSEcCtD
Pioglitazone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000876	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.000871	CcSEcCtD
Pioglitazone—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000871	CcSEcCtD
Pioglitazone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000368	0.00087	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000869	CcSEcCtD
Pioglitazone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000364	0.000862	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000859	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000859	CcSEcCtD
Pioglitazone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000359	0.000849	CcSEcCtD
Pioglitazone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000358	0.000847	CcSEcCtD
Pioglitazone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000354	0.000839	CcSEcCtD
Pioglitazone—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000835	CcSEcCtD
Pioglitazone—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000833	CcSEcCtD
Pioglitazone—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00035	0.000829	CcSEcCtD
Pioglitazone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000349	0.000827	CcSEcCtD
Pioglitazone—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000827	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000823	CcSEcCtD
Pioglitazone—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000823	CcSEcCtD
Pioglitazone—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000821	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000819	CcSEcCtD
Pioglitazone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000819	CcSEcCtD
Pioglitazone—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000817	CcSEcCtD
Pioglitazone—Headache—Vincristine—peripheral nervous system neoplasm	0.000345	0.000817	CcSEcCtD
Pioglitazone—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.000806	CcSEcCtD
Pioglitazone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000803	CcSEcCtD
Pioglitazone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000333	0.000789	CcSEcCtD
Pioglitazone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000779	CcSEcCtD
Pioglitazone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000329	0.000778	CcSEcCtD
Pioglitazone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000773	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000771	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000767	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000765	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000761	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000759	CcSEcCtD
Pioglitazone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00032	0.000758	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000757	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000756	CcSEcCtD
Pioglitazone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000752	CcSEcCtD
Pioglitazone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000751	CcSEcCtD
Pioglitazone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000743	CcSEcCtD
Pioglitazone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000725	CcSEcCtD
Pioglitazone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000305	0.000722	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.00072	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000715	CcSEcCtD
Pioglitazone—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000715	CcSEcCtD
Pioglitazone—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000701	CcSEcCtD
Pioglitazone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000295	0.000698	CcSEcCtD
Pioglitazone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000697	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000696	CcSEcCtD
Pioglitazone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000695	CcSEcCtD
Pioglitazone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000673	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000671	CcSEcCtD
Pioglitazone—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000283	0.00067	CcSEcCtD
Pioglitazone—Headache—Etoposide—peripheral nervous system neoplasm	0.000279	0.000661	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000661	CcSEcCtD
Pioglitazone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000654	CcSEcCtD
Pioglitazone—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000652	CcSEcCtD
Pioglitazone—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000649	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000645	CcSEcCtD
Pioglitazone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000626	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000623	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.00062	CcSEcCtD
Pioglitazone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000617	CcSEcCtD
Pioglitazone—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000617	CcSEcCtD
Pioglitazone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000617	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000613	CcSEcCtD
Pioglitazone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000258	0.00061	CcSEcCtD
Pioglitazone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000605	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000603	CcSEcCtD
Pioglitazone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000592	CcSEcCtD
Pioglitazone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000592	CcSEcCtD
Pioglitazone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000588	CcSEcCtD
Pioglitazone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000245	0.00058	CcSEcCtD
Pioglitazone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000579	CcSEcCtD
Pioglitazone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000575	CcSEcCtD
Pioglitazone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000572	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000571	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000571	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000571	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000567	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000564	CcSEcCtD
Pioglitazone—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000548	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000548	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000544	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000539	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000537	CcSEcCtD
Pioglitazone—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000535	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000532	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000529	CcSEcCtD
Pioglitazone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000528	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000511	CcSEcCtD
Pioglitazone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00051	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000499	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000495	CcSEcCtD
Pioglitazone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000488	CcSEcCtD
Pioglitazone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000488	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000473	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000472	CcSEcCtD
Pioglitazone—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000199	0.00047	CcSEcCtD
Pioglitazone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000451	CcSEcCtD
Pioglitazone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000436	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000435	CcSEcCtD
Pioglitazone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000425	CcSEcCtD
Pioglitazone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000405	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000403	CcSEcCtD
Pioglitazone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000393	CcSEcCtD
Pioglitazone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000391	CcSEcCtD
Pioglitazone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000375	CcSEcCtD
Pioglitazone—Headache—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000371	CcSEcCtD
Pioglitazone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000362	CcSEcCtD
Pioglitazone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000343	CcSEcCtD
